SSA
RGNX icon

Schonfeld Strategic Advisors’s Regenxbio RGNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,151
Closed -$119K – 2935
2026
Q1 		$119K Buy
+14,151
New +$149K ﹤0.01% 1855
2024
Q4 		– Sell
-124,632
Closed -$1.31M – 2328
2024
Q3 		$1.31M Buy
124,632
+75,512
+154% +$921K 0.01% 1065
2024
Q2 		$575K Sell
49,120
-134,675
-73% -$2.1M ﹤0.01% 1432
2024
Q1 		$3.87M Buy
+183,795
New +$3.27M 0.03% 735
2022
Q4 		– Sell
-7,578
Closed -$200K – 2943
2022
Q3 		$200K Buy
+7,578
New +$225K ﹤0.01% 2343
2019
Q4 		– Sell
-10,900
Closed -$387K – 1462
2019
Q3 		$387K Sell
10,900
-31,400
-74% -$1.27M 0.01% 718
2019
Q2 		$2.17M Sell
42,300
-46,800
-53% -$2.34M 0.08% 275
2019
Q1 		$5.11M Buy
+89,100
New +$4.41M 0.18% 155
2018
Q4 		– Sell
-25,700
Closed -$1.94M – 1209
2018
Q3 		$1.94M Sell
25,700
-84,200
-77% -$6.07M 0.09% 288
2018
Q2 		$7.89M Buy
109,900
+59,900
+120% +$2.86M 0.43% 52
2018
Q1 		$1.49M Sell
50,000
-108,687
-68% -$3.16M 0.11% 249
2017
Q4 		$5.28M Buy
158,687
+18,567
+13% +$559K 0.43% 62
2017
Q3 		$4.62M Buy
140,120
+65,120
+87% +$1.47M 0.42% 72
2017
Q2 		$1.48M Sell
75,000
-1,911
-2% -$37K 0.15% 199
2017
Q1 		$1.49M Buy
76,911
+36,911
+92% +$712K 0.15% 192
2016
Q4 		$742K Buy
+40,000
New +$764K 0.1% 270

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Schonfeld Strategic Advisors's RGNX Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 14,151 shares — an estimated $119K sold.

Schonfeld Strategic Advisors first reported a position in RGNX in Q4 2016 and held it in 16 quarters. The position peaked at $7.89M in Q2 2018. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 14,151 Regenxbio shares in Q2 2026, an estimated $119K.
  • Schonfeld Strategic Advisors first reported a position in Regenxbio in Q4 2016 and held it in 16 quarters.
  • Schonfeld Strategic Advisors's Regenxbio position peaked at $7.89M in Q2 2018.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.